Abbott Laboratories (ABT)
117.76
+0.50
(+0.43%)
USD |
NYSE |
Nov 22, 16:00
117.76
0.00 (0.00%)
Pre-Market: 20:00
Abbott Laboratories Free Cash Flow: 6.486B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.486B |
| June 30, 2024 | 5.654B |
| March 31, 2024 | 4.923B |
| December 31, 2023 | 5.059B |
| September 30, 2023 | 4.492B |
| June 30, 2023 | 5.488B |
| March 31, 2023 | 6.823B |
| December 31, 2022 | 7.804B |
| September 30, 2022 | 8.541B |
| June 30, 2022 | 8.468B |
| March 31, 2022 | 8.152B |
| December 31, 2021 | 8.648B |
| September 30, 2021 | 9.314B |
| June 30, 2021 | 8.644B |
| March 31, 2021 | 7.609B |
| December 31, 2020 | 5.724B |
| September 30, 2020 | 4.587B |
| June 30, 2020 | 4.564B |
| March 31, 2020 | 4.476B |
| December 31, 2019 | 4.498B |
| September 30, 2019 | 3.814B |
| June 30, 2019 | 4.096B |
| March 31, 2019 | 4.45B |
| December 31, 2018 | 4.906B |
| September 30, 2018 | 4.903B |
| Date | Value |
|---|---|
| June 30, 2018 | 4.816B |
| March 31, 2018 | 4.966B |
| December 31, 2017 | 4.435B |
| September 30, 2017 | 3.991B |
| June 30, 2017 | 3.154B |
| March 31, 2017 | 2.72B |
| December 31, 2016 | 2.082B |
| September 30, 2016 | 1.811B |
| June 30, 2016 | 1.69B |
| March 31, 2016 | 1.753B |
| December 31, 2015 | 1.856B |
| September 30, 2015 | 2.227B |
| June 30, 2015 | 2.367B |
| March 31, 2015 | 2.284B |
| December 31, 2014 | 2.598B |
| September 30, 2014 | 2.969B |
| June 30, 2014 | 2.29B |
| March 31, 2014 | 2.074B |
| December 31, 2013 | 2.179B |
| September 30, 2013 | 1.974B |
| June 30, 2013 | 4.718B |
| March 31, 2013 | 5.933B |
| December 31, 2012 | 7.519B |
| September 30, 2012 | 7.529B |
| June 30, 2012 | 7.143B |
Free Cash Flow Range, Past 5 Years
4.476B
Minimum
Mar 2020
9.314B
Maximum
Sep 2021
6.498B
Average
6.105B
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Becton Dickinson & Co | 3.073B |
| ResMed Inc | 1.347B |
| QuidelOrtho Corp | -96.80M |
| iRhythm Technologies Inc | -87.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.705B |
| Cash from Investing (Quarterly) | -594.00M |
| Cash from Financing (Quarterly) | -1.576B |
| Free Cash Flow Per Share (Quarterly) | 1.230 |
| Free Cash Flow to Equity (Quarterly) | 1.924B |
| Free Cash Flow to Firm (Quarterly) | 2.192B |
| Free Cash Flow Yield | 3.15% |